Our Chief Executive Officer, Alex Bailey, discusses Tern Therapeutics:
Tern Therapeutics
Biotechnology Research
Washington, DC 882 followers
Going to the ends of the Earth to develop new gene therapies for rare diseases
About us
TERN THERAPEUTICS is a privately-held biotechnology company founded in 2023 with a new vision for speeding the development of transformative, one-time gene therapy medicines for rare diseases. Guided by a team of leading physicians, scientists, and business leaders and in collaboration with patient communities, we are driven to deliver transformative treatments with urgency to those living around the world with rare disease.
- Website
-
www.terntx.com
External link for Tern Therapeutics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Washington, DC
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
Get directions
Washington, DC, US